Lataa...
Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid
Zoledronic acid (ZOL) is an antiresorptive drug used to prevent bone loss in a variety of conditions, acting mainly through suppression of osteoclast activity. There is growing evidence that ZOL can also affect cells of the mesenchymal lineage in bone. We present novel data revealing significant cha...
Tallennettuna:
| Julkaisussa: | FASEB J |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Federation of American Societies for Experimental Biology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902700/ https://ncbi.nlm.nih.gov/pubmed/31490705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201900553RR |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|